Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9203531 | 0.74 | HSD17B10 (0.38) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL6233700 | 0.74 | — | — | |
| SCHEMBL10752310 | 0.71 | — | — | |
| SCHEMBL2259933 | 0.70 | — | — | |
| SCHEMBL13564666 | 0.69 | — | — | |
| Carbamic Acid SCHEMBL2360016 | 0.69 | GABRA5 (0.34) | ALDH1A1MEN1KMT2ALMNAHSD17B10 | |
| SCHEMBL11415710 | 0.69 | L3MBTL1 (0.59) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL11199790 | 0.68 | MEN1 (0.49) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL8432354 | 0.67 | HDAC1 (0.51) | ALDH1A1KMT2ALMNAMAPTCSNK2A1 | |
| SCHEMBL11027267 | 0.62 | ALDH1A1 (0.35) | ALDH1A1MEN1KMT2ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7368464-B2 | Preparation for the production of 1,2,4-triazolylmethyl-oxiranes | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-06 | — | — | US | disclosed |
| US-20050176967-A1 | Preparation for the production of 1,2,4-triazolymethyl-oxiranes | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176967-A1 | Preparation for the production of 1,2,4-triazolymethyl-oxiranes | AOC3, CBR3, AOC2 | ALDH1A1 158/4885MEN1 3982/4885KMT2A 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.